Soleno Therapeutics Inc (SLNO)

Operating CF Margin

27.46%

Quarterly · Period ending:

SLNO logo

SLNO Operating CF Margin

Latest reported27.46%
SLNO Quarterly Operating CF Margin (69.50% → 27.46%)
High-resolution chart · PNG

SLNO operating cf margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc Operating CF Margin — Quarterly
Period endingOperating CF Margin
27.4621%
53.095%
66.0911%
-38.6073%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-0.3717%
0%
-276,400%
-823.7736%
-947.1789%
-846.8085%
-1,033.2481%
-891.2752%
-1,398.5759%
-3,109.7826%
-7,034.375%
-8,222.7273%
0%
0%
0%
0%
0%
0%
0%
69.4965%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.